Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-5,131
Closed -$427K 548
2018
Q1
$427K Sell
5,131
-484
-9% -$43.6K 0.05% 269
2017
Q4
$531K Buy
5,615
+918
+20% +$96K 0.05% 256
2017
Q3
$549K Sell
4,697
-420
-8% -$53.1K 0.06% 238
2017
Q2
$644K Buy
5,117
+812
+19% +$103K 0.08% 189
2017
Q1
$576K Buy
4,305
+661
+18% +$84.2K 0.07% 221
2016
Q4
$365K Sell
3,644
-212
-5% -$20.7K 0.05% 333
2016
Q3
$363K Sell
3,856
-242
-6% -$20.4K 0.05% 318
2016
Q2
$328K Buy
4,098
+1,302
+47% +$101K 0.04% 320
2016
Q1
$203K Sell
2,796
-678
-20% -$50.5K 0.03% 444
2015
Q4
$377K Buy
+3,474
New +$387K 0.04% 288

Other funds holding INCY

Pitcairn's INCY Position: Q2 2018 in Review

Pitcairn sold out of Incyte (INCY) in Q2 2018, closing a stake of 5,131 shares — an estimated $427K sold.

Pitcairn first reported a position in INCY in Q4 2015 and held it in 10 quarters. The position peaked at $644K in Q2 2017. 453 funds tracked by Wall St. Rank hold INCY as of Q2 2018.

  • Pitcairn reported no remaining Incyte position as of Q2 2018 after selling out during the quarter.
  • Pitcairn sold 5,131 Incyte shares in Q2 2018, an estimated $427K.
  • Pitcairn first reported a position in Incyte in Q4 2015 and held it in 10 quarters.
  • Pitcairn's Incyte position peaked at $644K in Q2 2017.
  • 453 funds tracked by Wall St. Rank held Incyte as of Q2 2018.

Based on Pitcairn's 13F filing for Q2 2018, filed 2 Aug 2018.